Clinical Trial

Improving Awareness for Spatial Neglect With tDCS

Study acronym: ANOSO
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Brain-damaged patients can show severe neurological and cognitive deficits, and yet often remain strikingly unaware of these symptoms: this condition is called anosognosia. The aim of this study is to improve awareness in right-brain-damaged patients with Unilateral Spatial Neglect (USN) following stroke using transcranial direct current stimulation (tDCS). tDCS is a neuromodulatory technique that delivers low-intensity current to the brain facilitating (anodal tDCS) or inhibiting (cathodal tDCS) spontaneous neuronal activity. tDCS does not induce activity in resting neuronal networks, but modulates spontaneous neuronal activity: consequently, the amount and direction of effects critically depend on the previous state of the neural structures. We will test USN patients showing anosognosia for neglect symptoms. Different brain areas will be stimulated, to target explicit and implicit components of anosognosia, including parietal and frontal brain regions.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2021-04-13; most recent amendment 2025-05-23.
Trial Details
NCT Number NCT04845529
Lead Sponsor University of Geneva, Switzerland
Collaborators: University Hospital, Geneva
Conditions Stroke, Anosognosia, Neglect, Hemispatial
Enrollment 12 participants
Start Date 2026-12
Primary Completion 2027-01 (estimated)
Study Completion 2027-01 (estimated)
Updated on ClinicalTrials.gov 2025-05-30